Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

HLA-DRB4*01:14 is a null allele, and renamed HLA-DRB4*01:14N.

Fuerst D, Tsamadou C, Gowdavally S, Schrezenmeier H, Mytilineos J.

HLA. 2019 Oct 2. doi: 10.1111/tan.13701. [Epub ahead of print]

PMID:
31576671
2.

Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia.

Tsamadou C, Fürst D, Wang T, He N, Lee SJ, Spellman SR, Fleischhauer K, Hsu KC, Paczesny S, Verneris MR, Schrezenmeier H, Mytilineos J.

Biol Blood Marrow Transplant. 2019 Aug 16. pii: S1083-8791(19)30521-X. doi: 10.1016/j.bbmt.2019.08.007. [Epub ahead of print]

3.

Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.

Babor F, Peters C, Manser AR, Glogova E, Sauer M, Pötschger U, Ahlmann M, Cario G, Feuchtinger T, Gruhn B, Güngör T, Horn PA, Kremens B, Lang P, Mezger M, Müller I, Mytilineos J, Oevermann L, Pichler H, Scherenschlich N, Schuster FR, Siepermann M, Stachel D, Strahm B, Wössmann W, Escherich G, Zimmermann M, Schrappe M, Borkhardt A, Eckert C, Bader P, Uhrberg M, Meisel R.

Bone Marrow Transplant. 2019 Nov;54(11):1847-1858. doi: 10.1038/s41409-019-0543-z. Epub 2019 May 14.

PMID:
31089287
4.

Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.

Fürst D, Hauber D, Reinhardt P, Schauwecker P, Bunjes D, Schulz A, Mytilineos J, Wiesneth M, Schrezenmeier H, Körper S.

Vox Sang. 2019 Apr;114(3):275-282. doi: 10.1111/vox.12754. Epub 2019 Mar 14.

PMID:
30873634
5.

A novel allele of the atypical chemokine receptor 1 (ACKR1) gene containing the nucleotide change c.126 T>G (p.42Glu) encodes a third Duffy blood group protein sequence antithetical to that encoding Fya and Fyb antigens.

Weinstock C, Mytilineos J, Bugert P, Sitzmann N, Pensel E, Schrezenmeier H, Fürst D.

Transfusion. 2019 Jun;59(6):2158-2159. doi: 10.1111/trf.15232. Epub 2019 Mar 8. No abstract available.

PMID:
30848497
6.

Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Osoegawa K, Vayntrub TA, Wenda S, De Santis D, Barsakis K, Ivanova M, Hsu S, Barone J, Holdsworth R, Diviney M, Askar M, Willis A, Railton D, Laflin S, Gendzekhadze K, Oki A, Sacchi N, Mazzocco M, Andreani M, Ameen R, Stavropoulos-Giokas C, Dinou A, Torres M, Dos Santos Francisco R, Serra-Pages C, Goodridge D, Balladares S, Bettinotti MP, Iglehart B, Kashi Z, Martin R, Saw CL, Ragoussis J, Downing J, Navarrete C, Chong W, Saito K, Petrek M, Tokic S, Padros K, Beatriz Rodriguez M, Zakharova V, Shragina O, Marino SR, Brown NK, Shiina T, Suzuki S, Spierings E, Zhang Q, Yin Y, Morris GP, Hernandez A, Ruiz P, Khor SS, Tokunaga K, Geretz A, Thomas R, Yamamoto F, Mallempati KC, Gangavarapu S, Kanga U, Tyagi S, Marsh SGE, Bultitude WP, Liu X, Cao D, Penning M, Hurley CK, Cesbron A, Mueller C, Mytilineos J, Weimer ET, Bengtsson M, Fischer G, Hansen JA, Chang CJ, Mack SJ, Creary LE, Fernandez-Viña MA.

Hum Immunol. 2019 Apr;80(4):228-236. doi: 10.1016/j.humimm.2019.01.009. Epub 2019 Feb 6. Review.

7.

Common and well-documented HLA alleles of German stem cell donors by haplotype frequency estimation.

Eberhard HP, Schmidt AH, Mytilineos J, Fleischhauer K, Müller CR.

HLA. 2018 Oct;92(4):206-214. doi: 10.1111/tan.13378.

8.

Resequencing of four novel alleles with nanopore technology.

Fuerst D, Radecke F, Schrezenmeier H, Schwarz K, Mytilineos J.

HLA. 2018 Oct;92(4):233-234. doi: 10.1111/tan.13360. Epub 2018 Sep 4.

PMID:
30079498
9.

Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Ayuk F, Beelen DW, Bornhäuser M, Stelljes M, Zabelina T, Finke J, Kobbe G, Wolff D, Wagner EM, Christopeit M, Schmid C, Ottinger H, Groth C, Faul C, Bertz H, Rachlis E, Wolschke C, Schetelig J, Horn PA, Mytilineos J, Guellstorf M, Kelsch R, Fleischhauer K, Kröger N, Bethge W.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2558-2567. doi: 10.1016/j.bbmt.2018.06.026. Epub 2018 Jul 24.

PMID:
29966760
10.

Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.

Fuerst D, Frank S, Mueller C, Beelen DW, Schetelig J, Niederwieser D, Finke J, Bunjes D, Kröger N, Neuchel C, Tsamadou C, Schrezenmeier H, Beyersmann J, Mytilineos J.

Haematologica. 2018 Sep;103(9):1527-1534. doi: 10.3324/haematol.2017.183012. Epub 2018 Jun 7.

11.

MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.

Zingoni A, Vulpis E, Cecere F, Amendola MG, Fuerst D, Saribekyan T, Achour A, Sandalova T, Nardone I, Peri A, Soriani A, Fionda C, Mariggiò E, Petrucci MT, Ricciardi MR, Mytilineos J, Cippitelli M, Cerboni C, Santoni A.

Front Immunol. 2018 May 1;9:926. doi: 10.3389/fimmu.2018.00926. eCollection 2018.

12.

Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival.

Arnold ML, Bach C, Heinemann FM, Horn PA, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Schaub S, Hönger G, Fischer GF, Mytilineos J, Hallensleben M, Hitzler WE, Seidl C, Spriewald BM.

Int J Immunogenet. 2018 Jun;45(3):95-101. doi: 10.1111/iji.12363. Epub 2018 Mar 25.

PMID:
29575597
13.

Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients.

Tsamadou C, Fürst D, Vucinic V, Bunjes D, Neuchel C, Mytilineos D, Gramatzki M, Arnold R, Wagner EM, Einsele H, Müller C, Schrezenmeier H, Mytilineos J.

Haematologica. 2017 Nov;102(11):1947-1955. doi: 10.3324/haematol.2017.169805. Epub 2017 Sep 7.

14.

Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.

Theodoraki MN, Lorenz K, Lotfi R, Fürst D, Tsamadou C, Jaekle S, Mytilineos J, Brunner C, Theodorakis J, Hoffmann TK, Laban S, Schuler PJ.

Photodiagnosis Photodyn Ther. 2017 Sep;19:194-201. doi: 10.1016/j.pdpdt.2017.05.015. Epub 2017 May 31.

PMID:
28578124
15.

Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study.

Neuchel C, Fürst D, Niederwieser D, Bunjes D, Tsamadou C, Wulf G, Pfreundschuh M, Wagner E, Stuhler G, Einsele H, Schrezenmeier H, Mytilineos J.

PLoS One. 2017 Jan 20;12(1):e0169512. doi: 10.1371/journal.pone.0169512. eCollection 2017.

16.

Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation.

Fürst D, Niederwieser D, Bunjes D, Wagner EM, Gramatzki M, Wulf G, Müller CR, Neuchel C, Tsamadou C, Schrezenmeier H, Mytilineos J.

Haematologica. 2017 Apr;102(4):796-803. doi: 10.3324/haematol.2016.151340. Epub 2017 Jan 5.

17.

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.

Fuerst D, Neuchel C, Niederwieser D, Bunjes D, Gramatzki M, Wagner E, Wulf G, Glass B, Pfreundschuh M, Einsele H, Arnold R, Stuhler G, Schaefer-Eckart K, Freitag S, Casper J, Kaufmann M, Wattad M, Hertenstein B, Klein S, Ringhoffer M, Mytilineos D, Tsamadou C, Mueller C, Schrezenmeier H, Mytilineos J.

Blood. 2016 Dec 29;128(26):3169-3176. doi: 10.1182/blood-2016-05-716357. Epub 2016 Nov 3.

PMID:
27811019
18.

Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.

Becker P, Schwebig A, Brauninger S, Bialleck H, Luxembourg B, Schulz M, Tsamadou C, Wiesneth M, Reinhardt P, Mytilineos J, Seidl C, Gattu S, Kaliakina N, Singh P, Schrezenmeier H, Seifried E, Bonig H.

Transfusion. 2016 Dec;56(12):3055-3064. doi: 10.1111/trf.13853. Epub 2016 Sep 16.

PMID:
27633122
19.

Donor-specific antibodies require preactivated immune system to harm renal transplant.

Süsal C, Döhler B, Ruhenstroth A, Morath C, Slavcev A, Fehr T, Wagner E, Krüger B, Rees M, Balen S, Živčić-Ćosić S, Norman DJ, Kuypers D, Emonds MP, Pisarski P, Bösmüller C, Weimer R, Mytilineos J, Scherer S, Tran TH, Gombos P, Schemmer P, Zeier M, Opelz G; A Collaborative Transplant Study Report.

EBioMedicine. 2016 Jul;9:366-371. doi: 10.1016/j.ebiom.2016.06.006. Epub 2016 Jun 5.

20.

NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors.

Chitadze G, Lettau M, Luecke S, Wang T, Janssen O, Fürst D, Mytilineos J, Wesch D, Oberg HH, Held-Feindt J, Kabelitz D.

Oncoimmunology. 2015 Dec 10;5(4):e1093276. eCollection 2016 Apr.

21.

Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.

Fuerst D, Mueller C, Beelen DW, Neuchel C, Tsamadou C, Schrezenmeier H, Mytilineos J.

Haematologica. 2016 Feb;101(2):241-7. doi: 10.3324/haematol.2015.130401. Epub 2015 Nov 26.

22.

Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.

Zingoni A, Cecere F, Vulpis E, Fionda C, Molfetta R, Soriani A, Petrucci MT, Ricciardi MR, Fuerst D, Amendola MG, Mytilineos J, Cerboni C, Paolini R, Cippitelli M, Santoni A.

J Immunol. 2015 Jul 15;195(2):736-48. doi: 10.4049/jimmunol.1402643. Epub 2015 Jun 12.

23.

HLA typing by next-generation sequencing - getting closer to reality.

Gabriel C, Fürst D, Faé I, Wenda S, Zollikofer C, Mytilineos J, Fischer GF.

Tissue Antigens. 2014 Feb;83(2):65-75. doi: 10.1111/tan.12298. Review.

PMID:
24447174
24.

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Fürst D, Müller C, Vucinic V, Bunjes D, Herr W, Gramatzki M, Schwerdtfeger R, Arnold R, Einsele H, Wulf G, Pfreundschuh M, Glass B, Schrezenmeier H, Schwarz K, Mytilineos J.

Blood. 2013 Oct 31;122(18):3220-9. doi: 10.1182/blood-2013-02-482547. Epub 2013 Sep 17. Erratum in: Blood. 2014 Mar 13;123(11):1768.

PMID:
24046013
25.

Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.

Solgi G, Gadi V, Paul B, Mytilineos J, Pourmand G, Mehrsai A, Ranjbar M, Mohammadnia M, Nikbin B, Amirzargar AA.

Chimerism. 2013 Jul-Sep;4(3):87-94. doi: 10.4161/chim.24719. Epub 2013 May 31.

26.

Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.

Chitadze G, Lettau M, Bhat J, Wesch D, Steinle A, Fürst D, Mytilineos J, Kalthoff H, Janssen O, Oberg HH, Kabelitz D.

Int J Cancer. 2013 Oct 1;133(7):1557-66. doi: 10.1002/ijc.28174. Epub 2013 Apr 18.

27.

16(th) IHIW: anti-HLA alloantibodies of the of IgA isotype in re-transplant candidates.

Arnold ML, Heinemann FM, Horn P, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Fischer GF, Schaub S, Hallensleben M, Mytilineos J, Hitzler WE, Seidl C, Doxiadis II, Spriewald BM.

Int J Immunogenet. 2013 Feb;40(1):17-20. doi: 10.1111/iji.12032. Epub 2012 Dec 22.

PMID:
23280184
28.

TNFA promoter alleles--frequencies and linkage with classical HLA genes in a South German Caucasian population.

Fürst D, Zollikofer Ch, Schrezenmeier H, Mytilineos J.

Tissue Antigens. 2012 Dec;80(6):502-8. doi: 10.1111/tan.12025.

PMID:
23137321
29.

HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors.

Fuerst D, Parmar S, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kaechele V, Stiebel K, Paul T, Seufferlein T, Mytilineos J, Stingl JC.

Pharmacogenomics. 2012 Oct;13(13):1469-76. doi: 10.2217/pgs.12.122.

PMID:
23057547
30.

Cytokine genetic profile in Whipple's disease.

Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Mytilineos J, Garlaschelli F, Marchese A, Trotta L, Bianchi PI, Di Stefano M, Cremaschi AL, De Silvestri A, Salvaneschi L, Martinetti M, Corazza GR.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3145-50. doi: 10.1007/s10096-012-1677-8. Epub 2012 Jul 31.

PMID:
22847580
31.

Influence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donors.

Seyhun Y, Mytilineos J, Turkmen A, Oguz F, Kekik C, Ozdilli K, Nane I, Aydin F, Carin M.

Transplant Proc. 2012 Jul-Aug;44(6):1670-8. doi: 10.1016/j.transproceed.2012.05.046.

PMID:
22841241
32.

Influence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donors.

Seyhun Y, Mytilineos J, Turkmen A, Oguz F, Kekik C, Ozdilli K, Nane I, Aydin F, Carin M.

Transplant Proc. 2012 Jun;44(5):1241-9. doi: 10.1016/j.transproceed.2012.01.125.

PMID:
22663993
33.

Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia.

Greiner J, Ono Y, Hofmann S, Schmitt A, Mehring E, Götz M, Guillaume P, Döhner K, Mytilineos J, Döhner H, Schmitt M.

Blood. 2012 Aug 9;120(6):1282-9. doi: 10.1182/blood-2011-11-394395. Epub 2012 May 16.

PMID:
22592607
34.

Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial.

Solgi G, Mytilineos J, Gadi V, Paul B, Pourmand G, Mehrsai A, Nikbin B, Amirzargar AA.

Chimerism. 2011 Oct-Dec;2(4):102-10. doi: 10.4161/chim.2.4.19095.

35.

HLA-E polymorphisms in hematopoietic stem cell transplantation.

Fürst D, Bindja J, Arnold R, Herr W, Schwerdtfeger R, Müller CH, Recker K, Schrezenmeier H, Mytilineos J.

Tissue Antigens. 2012 Apr;79(4):287-90. doi: 10.1111/j.1399-0039.2011.01832.x. Epub 2012 Jan 18.

PMID:
22256791
36.

Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.

Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.

Transpl Immunol. 2012 Mar;26(2-3):81-7. doi: 10.1016/j.trim.2011.12.002. Epub 2011 Dec 13.

PMID:
22182633
37.

One amino acid change located in the conserved region of the alpha 1 domain specifies the novel HLA-C*07:147 allele.

Becker PS, Fürst D, Recker K, Mytilineos J, Seidl C.

Tissue Antigens. 2011 Oct;78(4):292-4. doi: 10.1111/j.1399-0039.2011.01715.x. Epub 2011 Jun 27.

PMID:
21707538
38.

Sequence-based typing of major histocompatibility complex class I chain-related gene A alleles by use of exons 2-5 information.

Fürst D, Solgi G, Recker K, Mytilineos D, Schrezenmeier H, Mytilineos J.

Tissue Antigens. 2011 Mar;77(3):201-5. doi: 10.1111/j.1399-0039.2010.01601.x.

PMID:
21299524
39.

A new polymorphic position in exon 2 shows the novel allele HLA-DPB1*123:01.

Witter K, Fürst D, Mytilineos J, Volgger A, Albert T, Zahn R, Kauke T.

Tissue Antigens. 2010 Oct;76(4):338-9. doi: 10.1111/j.1399-0039.2010.01517.x.

PMID:
20573064
40.

The frequency of DRB1*1454 in South German Caucasians.

Fürst D, Solgi G, Schrezenmeier H, Mytilineos J.

Tissue Antigens. 2010 Jul;76(1):57-9. doi: 10.1111/j.1399-0039.2010.01461.x. Epub 2010 Mar 4.

PMID:
20210922
41.

Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies.

Hirv K, Bloch K, Fischer M, Einsiedler B, Schrezenmeier H, Mytilineos J.

Bone Marrow Transplant. 2009 Oct;44(7):433-40. doi: 10.1038/bmt.2009.53. Epub 2009 Mar 16.

PMID:
19290000
42.

Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA.

Hinrichs J, Figueiredo C, Hirv K, Mytilineos J, Blasczyk R, Horn PA, Eiz-Vesper B.

Mol Immunol. 2009 Apr;46(7):1451-7. doi: 10.1016/j.molimm.2008.12.011. Epub 2009 Feb 4.

PMID:
19195705
43.

Cytokine single nucleotide polymorphisms in Iranian populations.

Amirzargar AA, Naroueynejad M, Khosravi F, Dianat SS, Rezaei N, Mytilineos J, Nikbin B.

Eur Cytokine Netw. 2008 Jun;19(2):104-12. doi: 10.1684/ecn.2008.0122. Epub 2008 Jun 1. Erratum in: Eur Cytokine Netw. 2011 Sep;22(3):159. Dianat, Saied [corrected to Dianat, Seyed Saied].

44.

No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.

Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J.

Transplantation. 2007 Apr 27;83(8):1055-8.

PMID:
17452895
45.

HLA-Cw*0740, a new allele mistyped by generic sequencing and identified by allelic separation.

Danzer M, Polin H, Schröder S, Mytilineos J, Gabriel C.

Tissue Antigens. 2007 Jan;69(1):100-2.

PMID:
17212714
46.

Disulfide bridge disruption in the alpha2 domain of the HLA class I molecule leads to low expression of the corresponding antigen.

Hirv K, Pannicke U, Mytilineos J, Schwarz K.

Hum Immunol. 2006 Aug;67(8):589-96. Epub 2006 May 24.

PMID:
16916654
47.

Distribution of 22 cytokine gene polymorphisms in the healthy Czech population.

Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J, Petrek M.

Int J Immunogenet. 2006 Aug;33(4):261-7.

PMID:
16893389
48.

A new PCR-SSP typing method for six single-nucleotide polymorphisms impairing the blood-clotting cascade as well as T-cell stimulation.

Meyer M, Czachurski D, Tran TH, Opelz G, Mytilineos J.

Tissue Antigens. 2005 Dec;66(6):650-5. Erratum in: Tissue Antigens. 2006 Mar;67(3):265. Hien, T [corrected to Tran, TH].

PMID:
16305681
49.

Analysis of KIR ligand incompatibility in human renal transplantation.

Tran TH, Mytilineos J, Scherer S, Laux G, Middleton D, Opelz G.

Transplantation. 2005 Oct 27;80(8):1121-3.

PMID:
16278595
50.

Description and characterization of two new HLA alleles, B*4051 and DRB1*1364, identified by sequence-based typing.

Czachurski D, Scollo A, Skambraks A, Perichon AM, Scherer S, Tran TH, Opelz G, Grappiolo I, Mytilineos J.

Tissue Antigens. 2005 Aug;66(2):151-5.

PMID:
16029439

Supplemental Content

Loading ...
Support Center